| Ytd | 20.24% | |
| 1y | 29.70% |
| Open | 24.00 | Prev Close | 24.04 | Low | 23.67 | High | 24.00 | Mkt Cap | 3.13B |
| Vol | 201.03K | Avg Vol | 1.01M | EPS | 2.35 | P/E | 10.23 | Forward P/E | 10.11 |
| Beta | 0.78 | Short Ratio | 5.97 | Inst. Own | 76.00% | Dividend | 0.96 | Div Yield | 3.99 |
| Ex Div Date | 05-15 | Earning | 07-29 | 50-d Avg | 22.88 | 200-d Avg | 21.22 | 1yr Est | 25.75 |
Funding is provided through the FHLBNY Small Business Recovery Grant Program Funding is provided thr
Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 a
ISELIN, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial
WHITE SULPHUR SPRINGS, Mont., July 09, 2026 (GLOBE NEWSWIRE) -- Sandfire Resources America Inc. ("Sa
Raymond James analyst Steve Moss maintains Provident Finl Servs (NYSE:PFS) with a Strong Buy and
ISELIN, N.J., July 01, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) annou
Toronto, Ontario--(Newsfile Corp. - June 25, 2026) - Tartisan Nickel Corp. (CSE: TN) (OTCQX: TTSRF)
Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCE
Today, American Ocean Minerals Corporation (AOMC) announced the successful completion of Expedition
Provident Bank, a leading New Jersey-based financial institution, announced today the appointment of
ISELIN, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial
AbbVie Announces European Commission Approval of SKYRIZIÂ (risankizumab) for the Treatment of Pediat
Expanded programs targeting Q1 CY27 completion & ML application HIGHLIGHTS GR Engineering appointed
Funds will be used to support revitalization plans for distressed neighborhoods Funds will be used t
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 4
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcorita
New TALVEYÂ (talquetamab-tgvs) plus DARZALEX FASPROÂ (daratumumab and hyaluronidase-fihj) data demon
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evalu
[url="]BeOne Medicines Ltd.[/url] (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company
[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it i
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility PR Newswir
Seasoned Wealth Management Executive to Lead Strategic Growth of Provident Bank's Wealth Management
Options markets are pricing in post-earnings swings of up to 50% this week, with regional banks in f
During Monday's session, 402 companies made new 52-week lows.
On Thursday, 930 stocks hit new 52-week lows.
Monday's morning session saw 253 companies set new 52-week highs.
Companies Reporting Before The Bell • Mastercard Inc. (NYSE:MA) is expected to report quarterly ear
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Thursday
Stocks Trading Ex Dividend For Thurs., Feb. 14, 2019